GlassScriptPhysician profile
Andrea Kirsch
NPI 1548421381
$2,522.02
in general payments reported to CMS, 2019-2025
22 companies · $417 in 2025
The $417 reported for 2025 was more than what 77% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $814 · 2022: $718 · 2023: $553 · 2024: $19.78 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $989.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $481.13 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $266.89 | 2021-2025 | |
| Evofem Biosciences, INC. | $255.97 | 2021-2025 | Phexxi, Solosec, Phexx |
| Therapeuticsmd, INC. | $235.25 | 2021-2022 | |
| Myovant Sciences INC. | $209.94 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $173.56 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $151.47 | 2021-2023 | |
| Exeltis, USA INC. | $118.64 | 2021-2023 | Slynd |
| Sage Therapeutics, LLC | $112.56 | 2022-2025 | Zurzuvae |
| Coopersurgical, INC. | $80.56 | 2021-2025 | Paragard T 380a, Paragard T 380a |
| Mylan Pharmaceuticals INC. | $65.82 | 2021-2022 | |
| Organon LLC | $61.62 | 2022-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $60.94 | 2023-2025 | Aptima, Affirm Prone Biopsy System |
| Avion Pharmaceuticals | $55.83 | 2021-2023 | Balcoltra |
| Daiichi Sankyo INC. | $50.98 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $33.47 | 2025 | |
| Supernus Pharmaceuticals, INC. | $21.98 | 2025 | Qelbree |
| Exact Sciences Corporation | $20.28 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $19.00 | 2022 | |
| Astellas Pharma US INC | $17.53 | 2025 | Veozah |
| Agile Therapeutics, INC. | $15.37 | 2021 | |
| Urovant Sciences INC | $13.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Kirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.